Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

01 January 2001

Real-time RT-PCR measurement of the modulation of Mu opiate receptor expression by nitric oxide in human mononuclear cells.

P Cadet, K Mantione, T V Bilfinger, G B Stefano

Med Sci Monit 2001; 7(6): BR1123-1128 :: ID: 428894

Abstract

BACKGROUND: In previous studies, we have attributed opiate alkaloid selectivityto a subtype of the neuronal mu receptor known as mu3, expressed on human blood cells. Opiate alkaloidactivation of this receptor subtype leads to the release of constitutively derived nitric oxide. In thisreport, we show by real-time RT-PCR that the NO donor S-nitroso-N-acetyl-penicillamine (SNAP) initiatesthe down regulation of mu receptor gene expression in human mononuclear cells after 30 minutes. Superoxidedismutase, a free radical scavenger, blocks the effect of SNAP. MATERIAL AND METHODS: Human mononuclearcells isolated from whole blood were treated with SNAP (100 microM), and also with SNAP plus superoxidedismutase (100 U/ml) at different time points. Real-time RT-PCR with total RNA extracted from the cellswas used to analyze expression of the mu opiate receptor. RESULTS: Mu opiate receptor gene expressionwas significantly down regulated in cells treated with SNAP at 30 min, and superoxide dismutase blockedthe effect of SNAP. At 2 and 6 hours, a rebound effect was observed as noted by an increase in mu receptorexpression, and at 24 hours mu receptor expression returned to control levels in the SNAP-treated cells.CONCLUSIONS: This study confirms that human mononuclear cells express the mu opiate receptor transcriptand demonstrates that nitric oxide is involved in regulation of its expression.

Keywords: Poly(ethylene glycol), liposome, Drug Delivery, protein adsorption, dysopsonization

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

12 Mar 2024 : Clinical Research  

Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...

Med Sci Monit In Press; DOI: 10.12659/MSM.943126  

0:00

12 Mar 2024 : Clinical Research  

Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...

Med Sci Monit In Press; DOI: 10.12659/MSM.943500  

0:00

12 Mar 2024 : Review article  

Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive Strategies

Med Sci Monit In Press; DOI: 10.12659/MSM.943240  

0:00

12 Mar 2024 : Clinical Research  

Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe Psoriasis

Med Sci Monit In Press; DOI: 10.12659/MSM.943360  

0:00

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750